CPDA
CPDA is a novel potent SH2 domain-containing inositol phosphatase 2 (SHIP2) inhibitor.
Product Specifications
CAS Number
[1415834-63-7]
UNSPSC
12352005
Hazard Statement
H315, H319, H335
Target
Phosphatase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/CPDA.html
Purity
99.36
Solubility
DMSO : ≥ 50 mg/mL
Smiles
O=C(NC1=NC=CC(OCC2=CC=C(Cl)C=C2)=C1)CC3=C(F)C=CC=C3F
Molecular Formula
C20H15ClF2N2O2
Molecular Weight
388.80
Precautions
H315, H319, H335
References & Citations
[1]Rational design and synthesis of 4-substituted 2-pyridin-2-ylamides with inhibitory effects on SH2 domain-containing inositol 5'-phosphatase 2 (SHIP2) . Eur J Med Chem. 2013 Apr;62:649-660.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15375730 1 Vial
Lentiviral human ZNF557 sgRNA gene knockout kit - Lentiviral human ZNF557 sgRNA gene knockout kit (100)
Ask
View Details 